Business Wire
17 Oct 2026, 01:11 UTC · 15h ago
Impact · against what's priced in
Align Technology gains a legal lever to restrict Angelalign's sales in the EU, potentially increasing its market share and pricing power. This ruling creates a concrete threat of injunctions against a competitor's specific feature, providing a catalyst for growth in European markets.
No priced-in read yet
What the story claims
1 claim · scored −1 bearish … +1 bullish · 1 new · 0 priced in
The Unified Patent Court ruled that Angelalign's Torque Ridges feature infringes Align Technology's European Patent EP 2 237 738 B1.
Newpublished 2026-10-17, references decision
So whatThis ruling provides a legal basis for injunctions that could block Angelalign's sales in EU markets starting next quarter.
More positive than 94% of claims this week
Which stocks this story touches
Continue reading
5 related stories
The Unified Patent Court ruling that Angelalign's Torque Ridges infringe on Align's EP 2 237 738 B1 patent allows for injunctions that could block a competitor's sales in EU markets starting next quarter.
Read from the article alone
Scored by the NIS engine · methodology.
More positive than 90% of ticker scores this week
The company won a patent infringement ruling against a competitor in the Unified Patent Court.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
6h ago
—
ALGN hasn't traded since this ran. Last close $147.31 (Oct 16); the reaction starts at the next open.
ALGN chart →
